Benzocaine N-D-Fructoside (CAS 78306-17-9)

Benzocaine N-D-Fructoside is a novel chemical derivative combining benzocaine, a commonly known local anesthetic, with a fructoside moiety, thereby structurally modifying it into a glycosylated analog. This conjugation enhances the solubility and potentially alters the interaction of the compound with biological membranes. In research contexts, Benzocaine N-D-Fructoside is particularly interesting for studying the impact of glycosylation on the physicochemical properties and bioactivity of anesthetic compounds. The fructoside group in this molecule may influence its pharmacokinetic properties, such as absorption, distribution, metabolism, and excretion (ADME) processes, by making it more hydrophilic than its non-glycosylated counterpart. Scientists utilize this compound in biochemical assays to observe how the addition of sugar moieties affects the penetration of the anesthetic through lipid barriers, possibly altering its effectiveness at numbing local sites. Furthermore, the study of Benzocaine N-D-Fructoside helps explain the role of glycosylation in drug design, offering insights into how such modifications can be used to tailor the properties of pharmacologically active compounds for specific applications in research settings, particularly in understanding the interaction between chemical structure and biological function.